Caudal Block With Bupivacaine and Dexmedetomidine Versus TAP Block With Bupivacaine Alone for Postoperative Analgesia in Pediatric Undergoing Infraumbical Surgeries
- Conditions
- Postoperative Pain
- Interventions
- Registration Number
- NCT06183073
- Lead Sponsor
- Sohag University
- Brief Summary
Acute pain management for pediatric surgical patients intraoperatively and postoperatively is important for their comfort and psychological impact. Children aged 3-9 years old are included in the study and are divided randomly into two groups (45 children in each):
Group D: Caudal block with bupivacaine 0.25% in a dose of (1 ml / kg) and dexmedetomidine 1μg/ kg.
Group T: TAP block with bupivacaine 0.25% in a dose of (0.5 ml / kg).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 90
- Children aged 3-9 years old
- Physical status I and II class of the American Society of Anesthesiologists (ASA)
- Unilateral elective surgeries below the umbilicus
- Parents or legal guardian refusal.
- History of developmental delay or mental retardation
- Contraindications to regional anesthesia as known or suspected coagulopathy, a known allergy to any of the study drugs, signs of infection at the site of caudal block.
- Hemodynamic unstable patient.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Caudal block with bupivacaine and dexmedetomidine Bupivacain Caudal block with bupivacaine 0.25% in a dose of (1 ml / kg) and dexmedetomidine 1μg/ kg. Caudal block with bupivacaine and dexmedetomidine caudal block Caudal block with bupivacaine 0.25% in a dose of (1 ml / kg) and dexmedetomidine 1μg/ kg. TAP block with bupivacaine Bupivacain TAP block with bupivacaine 0.25% in a dose of (0.5 ml / kg). TAP block with bupivacaine TAP TAP block with bupivacaine 0.25% in a dose of (0.5 ml / kg). Caudal block with bupivacaine and dexmedetomidine Dexmedetomidine Caudal block with bupivacaine 0.25% in a dose of (1 ml / kg) and dexmedetomidine 1μg/ kg.
- Primary Outcome Measures
Name Time Method 1st analgesic requirement 12 hours Time for first analgesic request (paracetamol intravenously 15 mg/kg) (h)
- Secondary Outcome Measures
Name Time Method SpO2 -Hemodynamic assessment 12 hours post operative pain score 12 hours post operative pain score upon arrival to recovery room and then 2, 4,6, 8 , and 12 hours after surgery using Faces pain scale-revised.
diastolic Blood Pressure (BP) 12 hours Hemodynamic assessment
Total paracetamol consumption 12 hours Heart rate (HR) 12 hours Hemodynamic assessment
systolic Blood Pressure (BP) 12 hours Hemodynamic assessment
Trial Locations
- Locations (1)
Fouad Ibrahim Soliman
🇪🇬Sohag, Egypt